Tactile Systems Technology logo
Tactile Systems Technology TCMD
$ 27.4 -1.23%
report update icon

Annual report 2025
added 02-17-2026

Tactile Systems Technology Cash Flow 2025-2011 | TCMD

Brief cash flow overview of Tactile Systems Technology

The review uses the five latest available annual reports between 2021 and 2025.

Cash generated by core operations gained +1,527.2%, moving from $2.6 million to $42.8 million; annual growth near 100.8% was high.

Operating cash flow was positive in all five observations, adding repeatability to the cash profile.

Operating cash flow to net income stands at 3.65x. Accounting results have solid cash support.

Operating cash margin reached 13% versus 1.3% initially. Revenue converted into cash more effectively.

Conclusion

Tactile Systems Technology demonstrates high-quality cash generation. Operating and free cash flow leave a solid cushion for growth and obligations.

Annual Cash Flow Tactile Systems Technology

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

42.8 M 40.7 M 35.9 M 5.21 M 2.63 M 2.79 M 2.51 M 9.01 M 4.19 M 7.03 M 2.4 M - - - -

Depreciation & Amortization

6.64 M 6.79 M 6.54 M 6.27 M 3.68 M 2.79 M 3.54 M 3.74 M 1.8 M 799 K 827 K 706 K - - -

Accounts Payables

4.97 M 5.65 M 6.66 M 9.98 M 5.02 M 4.2 M 3.84 M 5.11 M 4.25 M 5.02 M - - - - -

Accounts Receivables

43.9 M 44.9 M 43.2 M 54.8 M 49.5 M 43.8 M 33.4 M 24.3 M 17.6 M 15 M - - - - -

Total Inventories

14 M 18.7 M 22.5 M 23.1 M 19.2 M 18.6 M 19.1 M 11.2 M 11 M 6.55 M - - - - -

All numbers in USD currency

Quarterly Cash Flow Tactile Systems Technology

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- - 417 K - - - 924 K - - - -502 K - 1.35 M - -3.21 M - -2.98 M - -800 K - -2.24 M -7.98 M 909 K - 2.42 M 851 K 1.27 M - 3.68 M -1.4 M -2.17 M - 33 K -3.02 M -316 K - 4.34 M 671 K - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

900 K 900 K 1.73 M - 900 K 1 M 1.63 M - 900 K 1 M 1.63 M - 1 M 1 M 1.51 M - 2.15 M 100 K 652 K - 2.1 M 1.45 M 730 K - 2.81 M 1.98 M 1.06 M - 2.47 M 1.69 M 463 K - 1.07 M 664 K 298 K - 675 K 437 K 211 K - 622 K 411 K - - - - - - - - - - - - - - - - -

Accounts Payables

7.99 M 8.02 M 7.22 M 5.65 M 7.29 M 5.09 M 5.49 M 6.66 M 6.4 M 9.3 M 9.59 M 9.98 M 11.2 M - 6.2 M 5.02 M 6.19 M 5.06 M 9.35 M 4.2 M 4.2 M 4.2 M 4.2 M 3.84 M 3.84 M 3.84 M 3.84 M 5.11 M 5.11 M 5.11 M 5.11 M 4.25 M 4.25 M 4.25 M 4.25 M 3.78 M 5.02 M 5.02 M 5.02 M 3.34 M 3.34 M 3.34 M - - - - - - - - - - - - - - - - -

Accounts Receivables

37.3 M 33.1 M 35.7 M 44.9 M 40 M 41.9 M 40.5 M 43.2 M 43.9 M 46.6 M 51 M 54.8 M 51.8 M - 45.9 M 49.5 M 44.3 M 42.6 M 40 M 43.8 M 43.8 M 43.8 M 43.8 M 33.4 M 33.4 M 33.4 M 33.4 M 24.3 M 24.3 M 24.3 M 24.3 M 17.6 M 17.6 M 17.6 M 17.6 M 15 M 15 M 15 M 15 M 14.2 M 14.2 M 14.2 M - - - - - - - - - - - - - - - - -

Total Inventories

16.1 M 17.1 M 18.9 M 18.7 M 21.2 M 18.8 M 20.8 M 22.5 M 23.5 M 20.3 M 20 M 23.1 M 23 M - 19.5 M 19.2 M 23.8 M 21.2 M 22 M 18.6 M 18.6 M 18.6 M 18.6 M 19.1 M 19.1 M 19.1 M 19.1 M 11.2 M 11.2 M 11.2 M 11.2 M 11 M 11 M 11 M 11 M 6.55 M 6.55 M 6.55 M 6.55 M 5.78 M 5.78 M 5.78 M - - - - - - - - - - - - - - - - -

All numbers in USD currency

Cash Flow Statement is one of the three key financial reports of the company Tactile Systems Technology, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.

Main Sections of the Cash Flow Statement
  • Operating Activities
    This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash.
  • Investing Activities
    Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign.
  • Financing Activities
    Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.

The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.

Cash flow statements of other stocks in the Medical devices sector

Issuer Price % 24h Market Cap Country
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Myomo Myomo
MYO
$ 0.93 -3.11 % $ 38.9 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
- - $ 162 M franceFrance
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 7.24 -0.14 % $ 219 M canadaCanada
AxoGen AxoGen
AXGN
$ 41.37 0.53 % $ 1.91 B usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
$ 3.38 -3.15 % $ 144 M usaUSA
AVITA Medical AVITA Medical
RCEL
$ 4.44 -3.69 % $ 124 M australiaAustralia
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 61.74 -1.86 % $ 9.37 B usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 32.66 0.31 % $ 28.3 B britainBritain
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 18.59 4.67 % $ 1.26 B usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 14.14 -2.68 % $ 400 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.86 -1.95 % $ 14.6 M usaUSA
Avanos Medical Avanos Medical
AVNS
$ 24.99 - $ 1.16 B usaUSA
Viemed Healthcare Viemed Healthcare
VMD
$ 11.65 -2.27 % $ 453 M usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
$ 10.95 -1.62 % $ 453 M usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.35 -4.32 % $ 21.8 M usaUSA
LENSAR LENSAR
LNSR
$ 5.25 -1.87 % $ 62.8 M usaUSA
Beyond Air Beyond Air
XAIR
$ 5.51 0.92 % $ 45.7 B usaUSA
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Xtant Medical Holdings Xtant Medical Holdings
XTNT
$ 0.43 0.14 % $ 60 M usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
Zimmer Biomet Holdings Zimmer Biomet Holdings
ZBH
$ 97.15 1.46 % $ 19.2 B usaUSA